MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition: Breast CancerInterventions: Drug: MK-3475; Behavioral: Follow Up/Phone CallSponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.Not yet recruiting - verified May 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials